Meredith Manning

Meredith Manning serves as the Chief Commercial Officer at Soleno Therapeutics, Inc., where the focus is on developing medicines for rare genetic disorders, particularly Prader-Willi syndrome. Previously, Meredith held the position of President, The Americas at PharmaEssentia, driving advancements in therapies for hematologic diseases. Additional experience includes roles as U.S. General Manager at resTORbio, Chief Commercial Officer at M Manning LLC, and significant positions at Shire and Baxalta in global product strategy and marketing for hemophilia. Early career achievements involve influential marketing roles at Baxter International, Vertex Pharmaceuticals, and Pfizer. Meredith holds an International MBA from The University of Chicago Booth School of Business and a Bachelor's degree in Political Science from Colorado College.